SocGen Takes Minority Stake in GMEX Group

French firm becomes an execution and clearing member of the venue.

david-escoffier
David Escoffier, deputy head of global markets for Société Générale CIB and CEO at Newedge.

SocGen Prime Services, formerly Newedge, has become the second minority investor in the London-based exchange after Deutsche Borse Group purchase a minority stake in 2013 for a figure in the "single-digit millions."

The French bank has also announced it will become an execution and clearing member of the venue.

“The GMEX Group offers genuinely new ways to trade Interest Rates via their unique and versatile Constant Maturity Futures product,” says David Escoffier, deputy head of global markets for SocGen's corporate and investment banking and CEO at Newedge. “That's exciting for our clients as they adapt to the new environment, for our industry, and for us as part of this venture. Acquiring a minority share reflects our commitment to driving innovation in the derivative markets, and we will continue to look positively at other similar initiatives based on innovation, quality and focus on delivery value to our clients."

 

 

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

A tech revolution in an old-school industry: FX

FX is in a state of transition, as asset managers and financial firms explore modernizing their operating processes. But manual processes persist. MillTechFX’s Eric Huttman makes the case for doubling down on new technology and embracing automation to increase operational efficiency in FX.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here